{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:58:06Z","timestamp":1792069086631,"version":"4.4.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The current study aims to assess incidence of postoperative macular edema (PME), risk factors behind PME and outcomes after cataract surgery in eyes with retinal vein occlusion (RVO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study included 162 eyes of 162 RVO patients, who underwent cataract surgery between 1 January 2015 and 31 December 2019. Eyes with RVO which did not have cystoid macular edema (CME) on optical coherence tomography (OCT) within the immediate 1 month prior to surgery were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patients were followed up for an average duration of 13 \u00b1 10.9 months after cataract surgery (range, 6\u201360 months). The mean time to PME development was 1.87 \u00b1 1.7 months. Postoperative macular edema developed within 3 months after surgery in 40.1% of all eyes, 21% eyes with no previous CME, 57.3% of eyes with previous CME, and in 50% of eyes of patients with diabetes. Significant risk factors of PME identified were diabetes (OR = 2.1) and previous CME (OR = 4.62) requiring treatment with anti-VEGF (OR = 4.83). The visual acuity (VA) of operated eyes significantly improved from 0.85 \u00b1 0.55 logMAR at baseline to 0.365 \u00b1 0.39 logMAR (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.0001) at the final follow-up. A significant proportion of eyes showed improvement of their VA beyond Snellen 6\/12 at final follow-up (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001); however, eyes with PME had a higher chance of poorer vision gain (worse than 6\/18). Poor prognostic factors for vision were presence of PME, previous CME and treatment history with injections, central RVO and poor VA at baseline.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The study demonstrates that RVO eyes with previous CME requiring intravitreal treatment are at significant risk of postoperative macular edema after uneventful cataract surgery, and this risk increases in people with diabetes. The incidence is not affected by the type of RVO. Considering almost 2\/3\n                      <jats:sup>rd<\/jats:sup>\n                      of PME developed within the 1\n                      <jats:sup>st<\/jats:sup>\n                      month of surgery, we recommend a routine OCT scan as a part of postoperative assessment at the 1\n                      <jats:sup>st<\/jats:sup>\n                      visit after surgery, in eyes at risk. Eyes developing PME may have poorer visual outcomes, especially eyes with CRVO; hence, patients need to be counseled carefully regarding outcomes of cataract surgery. The outcomes might depend on the previous treatment course they have received, and they may need to undergo a repeat cycle of treatment due to a risk of return of macular edema.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_1700_24","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:00:18Z","timestamp":1744873218000},"page":"864-869","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Risk factors and incidence of Macular Edema in eyes with retinal Vein Occlusion after uneventful cataract surgery: The MEVO study"],"prefix":"10.4103","volume":"73","author":[{"given":"Sagnik","family":"Sen","sequence":"first","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"},{"name":"Department of Medical Retina, Moorfields Eye Hospital, London, UK"},{"name":"Department of Vitreoretina, St Thomas Hospital, London, UK"},{"name":"UCL Institute of Ophthalmology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Damodaran","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithviraj","family":"Udaya","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Mallidi","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandralakshmi","family":"Chandrasekar","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthukrishnan","family":"Vallinayagam","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu P","family":"Rajan","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Shekhar","sequence":"additional","affiliation":[{"name":"Department of Intraocular Lens and Cataract Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh Babu","family":"Kannan","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Ramasamy","sequence":"additional","affiliation":[{"name":"Department of Retina and Vitreous, Aravind Eye Hospital, Madurai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/ICU.0b013e32834cd5f8","article-title":"Pseudophakic cystoid macular edema","volume":"23","author":"Yonekawa","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.survophthal.2014.08.005","article-title":"Management of pseudophakic cystoid macular edema","volume":"60","author":"Guo","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000331277","article-title":"Pseudophakic cystoid macular edema","volume":"227","author":"Lobo","year":"2012","journal-title":"Ophthalmologica"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ajo.2006.06.015","article-title":"Changes in visual acuity in a population over a 15-year period: The Beaver Dam Eye Study","volume":"142","author":"Klein","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ophtha.2015.10.001","article-title":"Risk factors and incidence of macular edema after cataract surgery: A database study of 81984 eyes","volume":"123","author":"Chu","year":"2016","journal-title":"Ophthalmology"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion: Six-month primary end point results of a phase III study","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ophtha.2014.01.027","article-title":"Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: Two-year results from the COPERNICUS study","volume":"121","author":"Heier","year":"2014","journal-title":"Ophthalmology"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/08820538.2015.1009555","article-title":"Outcomes of patients initially treated with intravitreal bevacizumab for central retinal vein occlusion: Long-term follow-up","volume":"31","author":"Bajric","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/sj.eye.6703040","article-title":"Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion","volume":"22","author":"Gunduz","year":"2008","journal-title":"Eye (Lond)"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 5","volume":"127","author":"Ip","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ophtha.2017.03.060","article-title":"Therapies for macular edema associated with branch retinal vein occlusion: A report by the american academy of ophthalmology","volume":"124","author":"Ehlers","year":"2017","journal-title":"Ophthalmology"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ophtha.2014.10.013","article-title":"Therapies for macular edema associated with central retinal vein occlusion: A report by the American academy of ophthalmology","volume":"122","author":"Yeh","year":"2015","journal-title":"Ophthalmology"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IAE.0b013e3182870c15","article-title":"Branch retinal vein occlusion: Epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature","volume":"33","author":"Jaulim","year":"2013","journal-title":"Retina"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: Pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/IAE.0000000000000843","article-title":"Retinal vein occlusions, from basics to the latest treatment","volume":"36","author":"Ho","year":"2016","journal-title":"Retina"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ophtha.2015.10.001","article-title":"Risk factors and incidence of macular edema after cataract surgery: A database study of 81984 eyes","volume":"123","author":"Chu","year":"2016","journal-title":"Ophthalmology"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08820538.2020.1772319","article-title":"Visual and anatomic outcomes following cataract surgery in patients with pre-operative macular edema due to retinal vein occlusions managed with intravitreal anti-VEGF","volume":"18","author":"Starr","year":"2020","journal-title":"Semin Ophthalmol"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/IAE.0000000000001668","article-title":"Macular edema after cataract surgery in eyes with preoperative retinal vein occlusion","volume":"38","author":"Cho","year":"2018","journal-title":"Retina"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.iae.0000249577.92800.c0","article-title":"Evaluation of costs for cystoid macular edema among patients after cataract surgery","volume":"27","author":"Schmier","year":"2007","journal-title":"Retina"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.ophtha.2014.04.035","article-title":"Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: A systematic review","volume":"121","author":"Kessel","year":"2014","journal-title":"Ophthalmology"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.04.001","article-title":"Ocular vascular occlusive disorders: Natural history of visual outcome","volume":"41","author":"Hayreh","year":"2014","journal-title":"Prog Retin Eye Res"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1700_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:55Z","timestamp":1787166715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1700_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1700_24","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"2024-07-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}